EAS Consulting Group, LLC (EAS) specializes in Food and Drug Administration (FDA) regulatory matters. Our prime focus is to assist domestic and foreign pharmaceutical, medical device, tobacco, food, dietary supplement, cosmetic and biologics firms comply with applicable laws and regulations. EAS is staffed with former FDA compliance and inspection officials and industry executives and is assisted by an extensive network of independent consultants with many years of FDA and industry experience.
Headquartered in Alexandria, VA with consultants and auditors located strategically throughout North and South America, Europe, and various Pacific Rim counties, EAS Consulting Group is a sought-after expert in regulatory matters, assisting firms with highly technical submissions such as GRAS, DMF, NDI, ANDA, 510(k) and others, as well as the development of quality systems, label reviews, structure-function claims, GMP audits, and US Agent assistance and more. In addition, EAS assists clients with remediation strategies and responding to Form 483’s, Lists of Observations, Warning Letters, and other FDA communications. EAS experts are often asked to serve as expert witnesses and are routinely asked to speak at worldwide events on technical regulatory issues. EAS is proud to have a solid reputation in the industry as the leading consulting and training firm for FDA regulatory matters.
Our mission is to provide quality regulatory advice and service and to represent the best interests of our clients in an ethical, timely, and cost-efficient manner.
The company’s roots go back nearly a half-century to 1960 when Arthur A. Checchi, former FDA Associate Commissioner, founded the company. In 1985 FDA’s Director of Regional Operations, Anthony C. Celeste, assumed the leadership of the company. He operated it under the name AAC Consulting Group (AAC). In 2001 the company was acquired by Kendle International, one of the world’s largest global clinical research organizations. In 2006 Mr. Steele, then President of AAC and Vice President of the company’s Regulatory Affairs, acquired the Division of Food, Dietary Supplement, and Cosmetic Consulting from Kendle. At that time he formed EAS Consulting Group as an independent company. In September 2007, pharmaceutical, medical device consulting was added to the list of services offered by EAS.
Arthur A. Checchi, a former FDA Associate Commissioner, founded the firm
Anthony Celeste, former Director of Regional Operations for FDA, takes over and operated the company as AAC Consulting Group
After 30 years, Edward A. Steele retires from the CFSAN at FDA and joins AAC as Vice President
AAC was acquired by Kendle International. Edward A. Steele, named President of AAC
October 10, 2006, Edward A. Steele, acquired the Food, Dietary Supplement, and Cosmetic consulting divisions and Founded EAS Consulting Group LLC
Edward A. Steele invites new partners to join EAS Consulting Group: Dean Cirotta as President and COO, Brett Steele as CFO. Expands Pharmaceutical, Medical Device, and Tobacco services
EAS Consulting Group successfully supports all FDA regulated industries with 12 staff members and over 150 independent Advisors and Consultants